Information for Patients

The modified Friedreich Ataxia Rating Scale (mFARS) is a clinically validated set of assessments that measures Friedreich ataxia (FA) progression and its impact on a patient’s ability to perform activities of daily living.1

In addition to evaluating disease progression, changes to mFARS scores over time have been typically accepted as an endpoint in clinical trials for potential new FA treatments.1

mFARS at a glance
Download the Understanding mFARS Flashcard now

Patient mFARS Composite Scores Will Typically Increase ~2 Points Per Year2

The mFARS identifies milestones in clinical outcome measures of FA progression.

A multicenter natural history study evaluated 812 patients diagnosed with FA annually, using multiple tests, including FARS and mFARS. The mean length of GAA triplet repeat was 636 and mean age of onset was 13.7 years.2

*Noted ages are at baseline.

The 4 mFARS Components

The mFARS includes traditional elements of a neuromuscular assessment that specifically focus on a patient’s disabilities.

Download the Understanding mFARS Flashcard

Watch Sub Subramony, MD, Neurology, University of Florida Health, discuss the clinical relevance of mFARS scores for patient mobility and independence.

mFARS

An overview of the mFARS assessments to measure disease progression and help predict the pace of future progression, with the goal of supporting independence as long as possible.

Bulbar Function

An important measure of the strength and volume of coughing and clarity of speech.

Upper Limb Coordination

Key assessments for motor abilities related to tremors, fine motor coordination, and steadiness of hands and arms.

Lower Limb Coordination and Upright Stability

Two essential assessments of sitting, standing, and walking, focusing on coordination of legs and feet, status of ambulation, and ability to coordinate voluntary movements.

Stay Connected

Sign up to receive the latest news and resources for FA.

I authorize Biogen, and companies working with Biogen, to contact me by mail, email, fax, telephone call, and text message (including autodialed and prerecorded calls and messages) for marketing purposes or otherwise provide me with information about Biogen’s products, services, and programs or other topics of interest, conduct market research or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Biogen for marketing, including targeted online marketing, as well as to help develop new products, services, and programs. I understand that Biogen will not sell or transfer my personal data to any unrelated third party for marketing purposes without my express permission. I understand that my consent is not required as a condition of purchasing or receiving any goods or services from Biogen. I understand that I may revoke this authorization and choose not to receive information from Biogen by mailing a letter to Biogen, 5000 Davis Drive, PO Box 13919, Research Triangle Park, NC, 27709, using the link provided in emails I receive from Biogen, clicking the “unsubscribe” link at the bottom of this page, or sending an email with the subject “Unsubscribe” to [email protected]. For more information visit http://biogen.com/privacy.

Residents of certain US States (including but not limited to California) may have additional rights regarding the collection, use, maintenance, disclosure, and deletion of your personal information. To understand or exercise those rights California residents please visit https://www.biogen.com/privacy-center/california-policy.html. For more information, visit https://www.biogen.com/privacy-center.html.

References: 1. Rummey C, Corben LA, Delatycki MB, et al. Psychometric properties of the Friedreich Ataxia Rating Scale. Neurol Genet. 2019;5(6):371. 2. Patel M, Isaacs CJ, Seyer L, et al. Progression of Friedreich ataxia: quantitative characterization over 5 years. Ann Clin Transl Neurol. 2016;3(9):684-694.

You are now leaving ThinkFA.com

You are now leaving ThinkFA.com. This link will take you to a website that is outside the control of Biogen. Links are provided as a courtesy for informational purposes only. We do not make or imply any endorsement of external websites.

Return to ThinkFA.com Continue

You are now leaving ThinkFA.com

You are about to leave ThinkFA.com. ConnectFA.com contains links that are provided as a courtesy for informational purposes only. We do not make or imply any endorsement of external websites.

Return to ThinkFA.com Continue